LobbyingInovio Pharmaceuticals lobbying by quarter
Inovio Pharmaceuticals INO's latest lobbying report covers Q2 2024, at $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Inovio PharmaceuticalsINO
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $180K | 2 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$316.7K · 5 reports
- Budget and appropriations$16.7K · 1 reports
- Defense$16.7K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)5 reports
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- White House Office5 reports
- Defense, Dept of (DOD)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseInovio Pharmaceuticals | $330K | 7 quarters |
| Cornerstone Government Affairs | $50K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRISTOPHER HODGSON | Legislative Assistant (Scalise), Floor Assistant & Deputy Floor Director for House Majority Whip (Scalise), Deputy Director & Director of Legislative Affairs (Pence) | Q4 2022 |
| SUSAN SWEAT | LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker) | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/16for Q2 2024 | In-house | $10K |
| 24/04/22for Q1 2024 | In-house | $20K |
| 24/01/18for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | $50K |
| 23/07/18for Q2 2023 | In-house | $60K |
| 23/04/20for Q1 2023 | In-house | $60K |
| 23/01/20for Q4 2022 | In-house | $130K |
| 23/01/20for Q4 2022 | Cornerstone Government Affairs | $50K |